Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative ReviewMojca Jensterle, Andrej Janež, Manfredi Rizzo et al.|Advances in Therapy|2022Cited by 205
The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert PanelMojca Jensterle, Manfredi Rizzo, Rok Herman et al.|International Journal of Molecular Sciences|2022Cited by 69
Post-COVID syndrome, inflammation, and diabetesAli A. Rizvi, Manfredi Rizzo, Mustafa Cesur et al.|Journal of Diabetes and its Complications|2022Cited by 69
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemiaYajnavalka Banerjee, Manfredi Rizzo, Anca Pantea Stoian et al.|Expert Opinion on Drug Safety|2021Cited by 53
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implementL. Rosta, Manfredi Rizzo, Adrienn Menyhárt et al.|Frontiers in Endocrinology|2023Cited by 31